1. Treatment Intensification in Patients With Kawasaki Disease and Coronary Aneurysm at Diagnosis
- Author
-
Dionne, Audrey, Burns, Jane C, Dahdah, Nagib, Tremoulet, Adriana H, Gauvreau, Kimberlee, de Ferranti, Sarah D, Baker, Annette L, Son, Mary Beth, Gould, Patrick, Fournier, Anne, Newburger, Jane W, and Friedman, Kevin G
- Subjects
Male ,Adolescent ,Clinical Trials and Supportive Activities ,Immunoglobulins ,Mucocutaneous Lymph Node Syndrome ,Medical and Health Sciences ,Pediatrics ,Rare Diseases ,Clinical Research ,Risk Factors ,hemic and lymphatic diseases ,Humans ,cardiovascular diseases ,Child ,Preschool ,Retrospective Studies ,Prevention ,Psychology and Cognitive Sciences ,Coronary Aneurysm ,Infant ,Infliximab ,Treatment Outcome ,6.1 Pharmaceuticals ,Antirheumatic Agents ,Immunization ,Female ,Intravenous ,Follow-Up Studies - Abstract
BackgroundCoronary artery aneurysms (CAA) are a serious complication of Kawasaki disease. Treatment with intravenous immunoglobulin (IVIg) within 10 days of fever onset reduces the risk of CAA from 25% to
- Published
- 2019